Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: OT: Time and Sales, 1/6/05

OT: Time and Sales, 1/6/05

posted on Jan 06, 2005 01:08PM
Rec. Time Action Price Volume

3:52:22 PM Bid 0.074 5000

3:52:16 PM Trade 0.075 20000

3:51:06 PM Ask 0.078 5000

3:42:40 PM Trade 0.076 10000

3:40:56 PM Ask 0.076 5000

3:23:04 PM Trade 0.075 300

3:09:30 PM Ask 0.077 5000

3:09:24 PM Trade 0.076 40000

2:57:44 PM Trade 0.075 10000

2:57:42 PM Ask 0.076 5000

2:57:40 PM Ask 0.078 5000

2:57:36 PM Bid 0.075 5000

2:57:34 PM Ask 0.076 5000

2:57:28 PM Ask 0.078 5000

2:57:28 PM Ask 0.076 5000

2:57:22 PM Trade 0.075 11000

2:57:22 PM Trade 0.075 27000

2:30:00 PM Trade 0.075 15000

2:26:08 PM Trade 0.075 3000

2:25:30 PM Trade 0.075 3200

2:25:26 PM Trade 0.075 1500

2:25:08 PM Trade 0.075 3000

2:25:06 PM Trade 0.075 2650

2:25:06 PM Ask 0.075 5000

2:24:28 PM Trade 0.076 20000

2:11:00 PM Bid 0.074 5000

2:10:56 PM Trade 0.075 20000

2:09:30 PM Trade 0.075 10000

1:41:36 PM Trade 0.076 39750

1:40:22 PM Ask 0.076 5000

1:38:04 PM Trade 0.077 5000

1:37:22 PM Trade 0.077 10000

1:37:22 PM Bid 0.075 5000

1:36:14 PM Trade 0.077 5000

1:34:02 PM Trade 0.077 5000

1:28:02 PM Trade 0.077 25000

1:14:48 PM Bid 0.073 5000

1:14:40 PM Trade 0.075 5200

12:44:04 PM Trade 0.077 25000

12:43:28 PM Trade 0.075 5000

12:43:14 PM Trade 0.075 5000

12:42:26 PM Ask 0.077 5000

12:24:24 PM Trade 0.075 225

11:29:42 AM Trade 0.078 40000

11:29:32 AM Trade 0.077 25000

11:29:32 AM Ask 0.078 5000

11:29:26 AM Trade 0.077 5000

11:29:18 AM Ask 0.077 5000

11:29:10 AM Trade 0.076 30000

10:51:58 AM Trade 0.076 4900

10:43:14 AM Trade 0.077 1000

10:29:36 AM Trade 0.077 1300

10:20:50 AM Trade 0.076 20000

10:09:24 AM Ask 0.077 5000

10:08:50 AM Trade 0.076 10000

10:02:52 AM Trade 0.076 2000

10:01:32 AM Trade 0.076 100

9:33:20 AM Trade 0.078 1000

9:31:24 AM Trade 0.078 1100

Share
New Message
Please login to post a reply